Caffeic Acid Phenethyl Ester Regulates PPAR's Levels in Stem Cells-Derived Adipocytes

Area of Science:

• Metabolic disease research
• Adipocyte biology
• Nutraceutical science

Background:

• Hypertrophic obesity impairs peroxisome proliferators-activated receptor gamma (PPARγ), crucial for insulin-sensitive adipocytes.
• Caffeic Acid Phenethyl Ester (Cape), derived from propolis, is investigated for its effects on adipocyte differentiation and function.

Purpose of the Study:

• To investigate Cape's impact on Adipose Stem Cells (ASCs) differentiation into adipocytes.
• To evaluate Cape's efficacy in improving insulin resistance in adipocytes.

Main Methods:

• Assessing lipid droplet formation and reactive oxygen species using Oil Red O staining.
• Measuring adiponectin and pro-inflammatory cytokine mRNA levels under high glucose conditions.
• Analyzing triglyceride synthesis, beta-oxidation, and PPARγ activation.

Main Results:

• Cape treatment reduced lipid droplets and reactive oxygen species.
• Cape reversed high glucose-induced decreases in adiponectin and increases in pro-inflammatory cytokines.
• Cape enhanced insulin sensitivity, decreased triglyceride synthesis, and increased beta-oxidation.
• Cape partially attenuated LPS-induced reduction of PPARγ and increase in IL-6.

Conclusions:

• Cape plays a significant role in adipocyte function and ASC differentiation, primarily through PPARγ.
• Cape demonstrates therapeutic potential for insulin-resistance related conditions, highlighting its value in functional foods and nutraceuticals.